Vol 82, No 6 (2024)
Editorial
Published online: 2024-06-04
The importance of glycemic control in regulating clot properties in CAD patients with concomitant diabetes
Abstract
Not available
References
- Litvinov RI, Pieters M, de Lange-Loots Z, et al. Fibrinogen and Fibrin. Subcell Biochem. 2021; 96: 471–501.
- Dunn EJ, Ariëns RAS, Grant PJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologia. 2005; 48(6): 1198–1206.
- de Vries JJ, Hoppenbrouwers T, Martinez-Torres C, et al. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation. Int J Mol Sci. 2020; 21(19).
- Konieczynska M, Fil K, Bazanek M, et al. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Thromb Haemost. 2014; 111(4): 685–693.
- Pieters M, Covic N, Loots DuT, et al. The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects. Thromb Haemost. 2006; 96(5): 623–629.
- Pieters M, Covic N, van der Westhuizen FH, et al. Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model. Thromb Haemost. 2008; 99(4): 691–700.
- Gajos G, Konieczynska M, Zalewski J, et al. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk. Cardiovasc Diabetol. 2015; 14: 44.
- Bryk AH, Konieczyńska M, Polak M, et al. Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study. Cardiovasc Diabetol. 2021; 20(1): 47.
- Dunn EJ, Ariëns RAS. Fibrinogen and fibrin clot structure in diabetes. Herz. 2004; 29(5): 470–479.
- Undas A, Wiek I, Stêpien E, et al. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008; 31(8): 1590–1595.
- Bochenek M, Zalewski J, Sadowski J, et al. Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease. J Thromb Thrombolysis. 2013; 35(2): 264–270.
- Neergaard-Petersen S, Hvas AM, Kristensen SD, et al. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease. Thromb Haemost. 2014; 112(6): 1142–1150.
- Sumaya W, Wallentin L, James SK, et al. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study. Thromb Haemost. 2020; 120(3): 412–422.
- Siniarski A, Gołębiowska-Wiatrak R, Malinowski KP, et al. Blood clot properties, thrombin generation and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study. Pol Heart J. 2024 [Epub ahead of print].
